Hepatic miR-34a overexpression was observed in NAFLD, and miR-34a upregulation caused steatosis by downregulating peroxisome proliferator-activated receptor alpha (PPARα) and sirtuin 1 (SIRT1) [10]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.